Compare Johnson & Johnson (JNJ) vs Impinj Inc (PI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Impinj Inc — how do they compare? Johnson & Johnson trades at $260.51 (market cap $626.09B), while Impinj Inc trades at $180 (market cap $5.32B). The key difference: Johnson & Johnson is far larger — about 117.7× Impinj Inc's market cap, and Johnson & Johnson pays a 2.06% dividend while Impinj Inc pays none. Which is the better fit depends on your goals.
| JNJ | PI | |
|---|---|---|
Market Cap | $626.09B | $5.32B |
Volume | 6,156,228 | — |
Sector | Health | Technology |
52-Week High | $267.24 | $241.91 |
52-Week Low | $172.78 | $91.34 |
Enterprise Value | $654.37B | $5.45B |
Dividend Yield | 2.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Impinj (PI) trades at $179.58, up 1.89% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $186. The stock shows strong revenue growth and recent earnings beats, but faces profitability challenges with negative net income margins. Recent news highlights institutional buying and record Q2 2026 results, driving positive sentiment.
Outlook: Upside potential exists from analyst targets and RFID market growth, but risks include persistent losses and high valuation multiples. Investment appeal hinges on margin improvement and execution against guidance, with current levels near resistance requiring careful entry timing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Impinj Inc
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →
